Home

RODNEY W LAPPE

CIK 1579826 · last filed 2026-06-11

RODNEY W LAPPE is a corporate insider who has filed 18 SEC Form 4 insider transactions across 2 companies since 2014. The most recent filing, for DSGN, was dated Jun 11, 2026. Across all open-market trades the lifetime net is +$268.7K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.9M across reported positions. 2 SEC filings were submitted jointly with Boxer Capital, LLC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.95M

Companies

2

Total Filings

18

Lifetime Open-Market Net

$268.7K

Filer Profile

Reported Address
C/O MIRATI THERAPEUTICS INC.
4660 LA JOLLA VILLAGE DRIVE, SUITE 500
SAN DIEGO, CA 92121
Related Filers
Boxer Capital, LLC — 2 joint filings, latest 2017-10-03
Aaron I. Davis — 2 joint filings, latest 2017-10-03
Shehan Bharatha Dissanayake — 2 joint filings, latest 2017-10-03
Christopher Fuglesang — 2 joint filings, latest 2017-10-03
JOSEPH LEWIS — 2 joint filings, latest 2017-10-03
IVAN M LIEBERBURG — 2 joint filings, latest 2017-10-03
MVA Investors, LLC — 2 joint filings, latest 2017-10-03
Neil Reisman — 2 joint filings, latest 2017-10-03
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
DSGN Director 133,024 $14.63 $1.95M $268.7K 11 2026-06-11
Mirati Therapeutics, Inc. (MRTX) Delisted Director — $58.70 — $0 7 2019-01-22

Recent Filings

18 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-11 DSGN Grant (A) — $0 EDGAR
2025-06-12 DSGN Grant (A) — $0 EDGAR
2025-01-06 DSGN Grant (A) — $0 EDGAR
2024-06-17 DSGN Grant (A) — $0 EDGAR
2023-12-05 DSGN Grant (A) — $0 EDGAR
2023-10-02 DSGN Buy (P) +21,000 $49.3K EDGAR
2023-06-02 DSGN Grant (A) — $0 EDGAR
2022-12-12 DSGN Buy (P) +15,000 $119.4K EDGAR
2022-06-16 DSGN Grant (A) — $0 EDGAR
2021-04-01 DSGN Buy (P) +5,000 $100.0K EDGAR
Showing 1–10 of 18
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.